HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hai Duc Nguyen Selected Research

Abdominal obesity metabolic syndrome

6/2022The effects of chemical mixtures on lipid profiles in the Korean adult population: threshold and molecular mechanisms for dyslipidemia involved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hai Duc Nguyen Research Topics

Disease

5Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2022 - 01/2021
4Cardiovascular Diseases (Cardiovascular Disease)
11/2022 - 01/2021
4Alzheimer Disease (Alzheimer's Disease)
10/2022 - 01/2022
4Cognitive Dysfunction
10/2022 - 01/2022
3Hypertension (High Blood Pressure)
01/2022 - 01/2021
2Non-alcoholic Fatty Liver Disease
11/2022 - 09/2022
2Inflammation (Inflammations)
10/2022 - 07/2022
2Dyslipidemias (Dyslipidemia)
06/2022 - 01/2022
2Obesity
03/2022 - 01/2022
2Arthritis (Polyarthritis)
01/2022 - 01/2022
1Neuroinflammatory Diseases
10/2022
1Alcoholic Fatty Liver
09/2022
1Atherosclerosis
07/2022
1Memory Disorders (Memory Loss)
07/2022
1Abdominal obesity metabolic syndrome
06/2022
1Noncommunicable Diseases
03/2022
1Insulin Resistance
01/2022
1Osteoarthritis
01/2022
1Myocardial Infarction
01/2022
1Dementia (Dementias)
01/2022
1Stroke (Strokes)
01/2022
1Hyperlipidemias (Hyperlipidemia)
01/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Hypoglycemia (Reactive Hypoglycemia)
01/2021

Drug/Important Bio-Agent (IBA)

8Heavy MetalsIBA
11/2022 - 01/2021
7MicroRNAs (MicroRNA)IBA
11/2022 - 01/2022
6MercuryIBA
11/2022 - 01/2021
5LipidsIBA
11/2022 - 01/2022
5CadmiumIBA
11/2022 - 01/2021
4Transcription Factors (Transcription Factor)IBA
11/2022 - 01/2022
4CytokinesIBA
10/2022 - 03/2022
3IronIBA
03/2022 - 01/2022
2CholesterolIBA
11/2022 - 06/2022
2Lipoproteins (Lipoprotein)IBA
11/2022 - 07/2022
2CurcuminIBA
10/2022 - 01/2022
2Interleukin-6 (Interleukin 6)IBA
10/2022 - 07/2022
2Caspase 3 (Caspase-3)IBA
07/2022 - 03/2022
2Thiamine (Aneurin)FDA Link
03/2022 - 01/2022
2ORALIT (ORS)IBA
01/2022 - 01/2021
2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2021
2VitaminsIBA
01/2022 - 01/2021
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2022 - 01/2022
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2022 - 01/2022
1Cytochrome P-450 CYP1A2 (CYP1A2)IBA
11/2022
1Biomarkers (Surrogate Marker)IBA
11/2022
1Calmodulin (Calcium-Dependent Activator Protein)IBA
10/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2022
1Advanced Glycation End ProductsIBA
10/2022
1Interleukin-10 (Interleukin 10)IBA
10/2022
1Toll-Like Receptor 4IBA
10/2022
1Triggering Receptor Expressed on Myeloid Cells-1IBA
10/2022
1Interleukin-1beta (Interleukin 1 beta)IBA
10/2022
11,2-diacetylbenzeneIBA
10/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2022
1EnzymesIBA
09/2022
1Heme (Haem)IBA
07/2022
1Glucose (Dextrose)FDA LinkGeneric
07/2022
1Biological ProductsIBA
07/2022
1Apolipoproteins E (ApoE)IBA
07/2022
1Estrogen ReceptorsIBA
06/2022
1Triglycerides (Triacylglycerol)IBA
06/2022
1ArsenicIBA
03/2022
1CopperIBA
03/2022
1GoldIBA
03/2022
1NF-kappa B (NF-kB)IBA
03/2022
1lead acetateIBA
03/2022
1AluminumIBA
03/2022
1Pyrethrins (Pyrethroids)FDA Link
03/2022
1InsecticidesIBA
03/2022
1Vitamin B Complex (B Vitamins)IBA
01/2022
1Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA
01/2022
1Galanin Receptors (Galanin Receptor)IBA
01/2022
1CalciumIBA
01/2022
1Phosphorus (Red Phosphorus)IBA
01/2022
1PotassiumIBA
01/2022
1Monounsaturated Fatty AcidsIBA
01/2022
1Interleukin-18 (Interleukin 18)IBA
01/2022
1CotinineIBA
01/2021
1C-Reactive ProteinIBA
01/2021
1Dipeptidyl-Peptidase IV InhibitorsIBA
01/2021
14- (3- amino- 4- (2,4,5- trifluorophenyl)butanoyl)- 3- (tert- butoxymethyl)piperazin- 2- oneIBA
01/2021

Therapy/Procedure

1Therapeutics
03/2022